pTRIPZ Myc2-mouse TTP WT Citations (1)

Originally described in: Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
Coelho MA, de Carne Trecesson S, Rana S, Zecchin D, Moore C, Molina-Arcas M, East P, Spencer-Dene B, Nye E, Barnouin K, Snijders AP, Lai WS, Blackshear PJ, Downward J Immunity. 2017 Dec 19;47(6):1083-1099.e6. doi: 10.1016/j.immuni.2017.11.016. Epub 2017 Dec 12. PubMed Journal

---

Articles Citing pTRIPZ Myc2-mouse TTP WT

Articles
Engineered Immunoagonist Non-Coding RNA (incRNA) Activates Dual TLR Pathways for Cancer Immunotherapy. Forster J 3rd, Fish A, Malhotra M, Pinjari A, Debnath M, Kulkarni A. Adv Healthc Mater. 2026 Jan;15(2):e03771. doi: 10.1002/adhm.202503771. Epub 2025 Sep 4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.